James Datin gave his notice as executive vice president and managing director to Safeguard Scientifics (NYSE:SFE) after 8 years with the healthcare holding and growth capital company, according to a press release.
Safeguard Scientifics Inc.
Merck backs Medivo in $15M in Series B round
Stung by widening losses, Accuray plans $75M debt offering | Wall Street Beat
Accuray (NSDQ:ARAY) plans to issue $75 million worth of convertible senior notes as it gears up to restructure its business after a year of widening losses.
The Sunnyvale, Calif.-based medical device company said it will use the proceeds from the offering of debt due Feb. 1, 2018, to shore up its balance sheet.
Safeguard Scientifics names Stephen Zarrilli CEO | Personnel Moves
Safeguard Scientifics gets a new CEO
Wayne, Pa.-based lifescience holdings company Safeguard Scientifics promoted its senior VP and CFO Stephen Zarrilli to CEO, effective on November 1. Zarrilli succeeds Peter Boni, who deployed approximately $315 million into 2-dozen high growth situations during his tenure in the corner office.
Former Wound Management CEO resigns as CFO, board member | Personnel Moves
Wound Management Technologies CFO and board member Scott Haire tenders resignation
Wound Management Technologies chief financial officer and board member Scott Haire tendered his full resignation, effective May 25, in a letter addressed to the company’s board of directors.
Safeguard leads $7 M funding round for Medivo | Funding Roundup
Safeguard Scientifics (NYSE:SFE) led a $7 million Series A financing round for health care IT company Medivo that provides data analytics and lab testing services.
Varian profits bounce 13 percent on increased sales | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Adjustable focus eyeglasses firm PixelOptics sees green after $45 million round
PixelOptics Inc. raised $45 million to support the commercialization and launch of what the company calls the "world’s first electronic focusing" eyeglasses.
Wayne, Pa.-based holding company Safeguard Scientifics Inc. (NYSE:SFE) led the round, ponying up $25 million for equity in the company, the companies said.
Dehaier profits are 70 percent higher | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days: